Biopreservation Market Size Report Segmented by Product (Equipment, Media, Laboratory Information System), Biospecimen (Tissue, Organ, Stem Cells), Application (Therapeutics, Research), End-user (Biobanks, Hospital, Gene Banks) Forecast to 2030

The biopreservation market is anticipated to grow at a CAGR of 15% during the forecast period. This growth is largely driven by the increasing demand for personalized medicine and cell-based therapies, rising number of biobanks and tissue banks, and growing R&D investments in life sciences and biotechnology. However, the high cost of these advanced equipment and the need for strict regulatory compliance, may hinder the market growth. To learn more about the research report, download a sample report.

Report Overview

Biopreservation refers to the method of preserving biological samples such as cells, tissues, blood, and organ. This method typically involves the use of cryogenic temperatures and chemical agents called cryoprotectants that prevent ice crystal formation, which may damage the cell structures. The technique ensures that the biological samples retain their structural and functional integrity during storage and after thawing. Biopreservation plays a significant role in biobanking, regenerative medicine, and the long-term storage of biospecimens for research and clinical trials.

To learn more about this report, download the PDF brochure

Stem cell therapies amplify need for advanced biopreservation solutions

The primary factor driving the biopreservation market is the rising demand for regenerative medicine, along with the growing demand for the therapies including stem cell therapy, gene editing, and tissue engineering which rely on the ability to store biological samples in a way that maintains their integrity over time. Biopreservation helps ensure that stem cells and tissues remain viable and effective, even after extended periods in storage. The growing adoption of stem cell for treating chronic conditions like diabetes, CVD, and Parkinson-s disease and the rising number of clinical trials associated with these therapies, underscores the need for advanced storage solutions. Additionally, healthcare institutions and biotech firms are investing in improved cold chain systems and standardized biobanking protocols to ensure sample qaceability. For instance, in April 2024, Thermo Fisher Scientific has introduced its new ENERGY STAR certified TSX Universal Series ultra-low temperature (ULT) freezers, designed to deliver better temperature control, faster recovery times, and enhanced energy efficiency, while supporting diverse laboratory workflows and sustainability goals

Improved post-thaw viability fuels vitrification adoption across applications

The biopreservation landscape is experiencing a noticeable evolution, shaped by a series of transformative trends. The growing preference for vitrification, a rapid freezing method that transforms biological sample into glass-like, solid states avoids ice crystal formation along with the development of safer, more efficient cryoprotectant formulations, which enhance sample viability. This method utilizes high concentrations of cryoprotectants combined with ultra-rapid cooling to prevent crystallization. This technique has been proved beneficial for sensitive cells like female egg cell, stem cell or embryos whose cell membrane can rupture in traditional slow freezing methods. Since this method has improved post-thaw survival rates and functionality, there is seen growing adoption of it in organ transplantation, regeneration research, and fertility preservation. Its success in minimizing structural damage during freezing and thawing has expanded its adoption in both clinical and research settings. Vitrification not only improves storage outcomes but also aligns with the growing need for precise, reproducible biopreservation methods as the scope of biomedical applications continues to grow.

To learn more about this report, download the PDF brochure

Competitive Landscape Analysis

The global biopreservation market is marked by the presence of established and emerging market players such as Azenta US, Inc.; Biomatrica, Inc. (Exact Sciences Corporation); BioLife Solutions; MVE Biological Solutions; Taylor-Wharton; Thermo Fisher Scientific, Inc.; LabVantage Solutions, Inc; X-Therma Inc.; PrincetonCryo.; Panasonic Healthcare Holdings, Co., Ltd; and Stirling Ultracoldamong others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Growth Rate

Report Metric	Details
Base Year Considered	2024
Historical Data	2023 - 2024
Forecast Period	2025 - 2030
15%
Market Drivers	Growing adoption of regenerative medicine and cell-based therapies Rising number of biobanks and tissue banks globally Increasing R&D investment in life sciences and biotechnology Expanding use of stem cells in chronic disease treatment Advances in cryopreservation and storage infrastructure
Attractive Opportunities	Growth in fertility preservation and reproductive biomedicine Rising demand for long-term organ preservation and transplant logistics Increasing focus on cold chain logistics for biopreserved samples Strategic collaborations between biotech firms and research institutions
Segment Scope	Product, Biospecimen, Application, and End-user
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Azenta US, Inc.; Biomatrica, Inc. (Exact Sciences Corporation); BioLife Solutions; MVE Biological Solutions; Taylor-Wharton; Thermo Fisher Scientific, Inc.; LabVantage Solutions, Inc; X-Therma Inc.; PrincetonCryo.; Panasonic Healthcare Holdings, Co., Ltd; and Stirling Ultracold among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Global Biopreservation Market Segmentation

This report by Medi-Tech Insights provides thesize of the global biopreservation market at theregional- and country-level from 2023 to 2030. The report further segments the market based on product, biospecimen, application, and end-user.

Market Size & Forecast (2023-2030), By Product, USD Million

• Equipment
  • Freezers
  • Refrigerators
  • Cryogenic Storage
  • Others
• Media
  • Cryopreservation
  • Hypothermic Preservation
• Lab Information Management System

Market Size & Forecast (2023-2030), By Biospecimen, USD Million

• Tissue
• Organs
• Stem cells
• Others

Market Size & Forecast (2023-2030), By Application, USD Million

Research

Market Size & Forecast (2023-2030), By End-user, USD Million

• Biobanks
• Hospitals
• Gene Banks
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Key Strategic Questions Addressed

• What is the market size & forecast of the biopreservation market?
• What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the biopreservation market?
• What are the key trends defining the market?
• What are the major factors impacting the market?
• What are the opportunities prevailing in the market?
• Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
• Who are the major players operating in the market?
• What are the key strategies adopted by players?